Skip to main navigation Skip to search Skip to main content

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

  • Shuchi Gulati
  • , McKenzie Crist
  • , Muhammed Kashif Riaz
  • , Vinita Takiar
  • , Maria Lehn
  • , Ilaina Monroe
  • , Sarah Palackdharry
  • , Nicky Kurtzweil
  • , Roman Jandarov
  • , Nusrat Harun
  • , Trisha M. Wise-Draper

Research output: Contribution to journal › Article › peer-review

30   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science